Quick answer: Most US insurance plans — commercial, Medicare, and most state Medicaid programs — cover the Dexcom G7, especially for people who use insulin. Getting it covered comes down to three things: a prescription written the way your plan wants it, any prior authorization your plan requires, and the claim going through the right benefit (pharmacy vs. medical/DME). That third one is where most people lose money. A free benefits check handles all three at once.
Who covers the G7
CGM coverage has expanded enormously in the last few years. As of 2026:
- Commercial plans (UnitedHealthcare, Aetna, Anthem, Cigna, Humana, and most regional plans) cover the G7 for people with diabetes on insulin, and increasingly for type 2 patients not on insulin when there's a documented clinical need. Dexcom reports most people with CGM coverage pay $20 or less a month once the claim runs through the right benefit — here's what Dexcom's own programs add.
- Medicare covers the G7 under Part B for insulin users and for people with a history of serious low-blood-sugar events. The rules are specific enough that we gave them their own page.
- Medicaid covers CGMs in the large majority of states, generally for insulin users; some states go further. Copays are usually zero or minimal.
The short version: if you have diabetes and use insulin, some form of coverage almost certainly exists for you. The question is rarely whether — it's how, and at what out-of-pocket cost.
Pharmacy vs. DME: the decision that quietly sets your price
Here's the part nobody explains at the doctor's office. Most insurance plans can pay for a CGM through two completely different doors:
- The pharmacy benefit — sensors are filled at a retail pharmacy like any prescription. Copays are often low and predictable.
- The medical/DME benefit — sensors come from a durable medical equipment supplier and are billed like medical equipment. This route often allows 90-day supplies shipped to your door, and on some plans (and most Medicare setups) it's the cheaper or the only covered lane.
The same person, the same plan, and the same box of sensors can cost meaningfully different amounts through each door. Which one wins depends on your specific plan design — deductibles, copay tiers, whether you've met your out-of-pocket max, and whether your plan even offers both routes.
This is honestly the single most valuable thing a benefits check does: it prices both lanes for your actual plan and picks the cheaper one, instead of defaulting to whichever door your prescription happened to be sent through.
The step-by-step path to coverage
-
Confirm your plan's CGM rules
Every plan documents what it needs — insulin use, a diagnosis code, sometimes glucose logs. You can call the number on your card and ask about "CGM coverage criteria," or let the coverage check pull this for you.
-
Get the prescription written to match
A G7 prescription that states insulin use and visit dates in the way the plan expects sails through. One that doesn't triggers weeks of faxes. This is a paperwork craft, not medicine — and it's exactly what a supplier's intake team does with your doctor's office.
-
Clear prior authorization, if required
Many plans want a short clinical form from your prescriber before the first fill. Handled proactively it takes days; discovered at the pharmacy counter, it's what turns into the classic "come back next week" loop.
-
Fill through the cheaper benefit
Pharmacy or DME, whichever your plan prices lower. If it's DME, a supplier like Medically Modern handles billing and ships 90 days of sensors at a time with refill reminders.
Prior authorization, demystified
"Prior auth" sounds ominous but is usually a one-page clinical questionnaire: diagnosis, insulin regimen, date of your last visit, occasionally a note about hypoglycemia history. Two things make it painless:
- Someone has to actually chase it. The form sits in a fax queue at your doctor's office unless someone follows up. When you go through a supplier, that chasing is their job, not yours.
- Renewals matter as much as the first one. Authorizations expire — commonly every 6 or 12 months. A good supplier tracks the expiration and renews it before your shipment is due, which is how you avoid the surprise gap in sensors.
If you've been denied
A denial is a starting position, not a verdict. In our experience most CGM denials fall into three fixable buckets:
- Wrong benefit. The claim went through pharmacy when your plan only covers CGM under DME (or the reverse). Fix: resubmit through the right door. This is the most common one by far.
- Missing documentation. The plan wanted insulin use or a recent visit documented and the paperwork didn't say it. Fix: your doctor's office resubmits with the missing detail — often a same-week fix.
- Genuine criteria mismatch. For example, a type 2 patient not on insulin whose plan hasn't caught up yet. Fix: a formal appeal with a letter of medical necessity, which succeeds more often than people expect — or a cash bridge using the discounts on this page while the appeal runs.
If you've been told "not covered" and never learned which bucket you were in, that's worth a second look before you accept retail prices. It costs nothing to have it re-checked.